PRESS RELEASE published on 04/08/2026 at 07:30, 4 months 10 days ago Evotec Announces Fourth Quarter and Full-Year 2025 Results: Foundation for Profitable Growth Evotec SE reports strong financial performance in Q4 and FY 2025, achieving group revenues of €253.3 million and €788.4 million respectively. Focus on profitable growth, strategic partnerships, and operational transformation for future success Strategic Partnerships Financial Performance Evotec SE Operational Transformation Q4 2025
BRIEF published on 04/07/2026 at 14:47, 4 months 11 days ago Evotec devrait empocher 100 millions de dollars grâce à la vente de Tubulis. Conjugués Anticorps-médicament Evotec Tubulis Stratégie De Monétisation Sciences De Gilead
BRIEF published on 04/07/2026 at 14:47, 4 months 11 days ago Evotec to Gain $100 Million from Tubulis Sale Antibody-drug Conjugates Evotec Tubulis Monetization Strategy Gilead Sciences
PRESS RELEASE published on 04/07/2026 at 14:42, 4 months 11 days ago Evotec to Receive Approx. $100 Million as Part of Tubulis Acquisition Evotec SE to receive approximately $100 million as part of Tubulis acquisition, marking continued execution of portfolio monetization strategy Acquisition Investment Monetization Evotec Tubulis
BRIEF published on 04/07/2026 at 07:35, 4 months 11 days ago Evotec Proposes Dieter Weinand as New Supervisory Board Chairman Strategic Partnerships Supervisory Board Evotec Pharmaceutical Leadership Dieter Weinand
BRIEF published on 04/07/2026 at 07:35, 4 months 11 days ago Evotec propose Dieter Weinand comme nouveau président du conseil de surveillance Partenariats Stratégiques Conseil De Surveillance Evotec Leadership Pharmaceutique Dieter Weinand
PRESS RELEASE published on 04/07/2026 at 07:30, 4 months 11 days ago Evotec Nominates Dieter Weinand as Supervisory Board Chairman Evotec SE nominates Dieter Weinand as Supervisory Board Chairman, aiming to enhance commercial execution, strategic partnerships, and profitability Strategic Partnerships Supervisory Board Chairman Evotec SE Commercial Execution Dieter Weinand
BRIEF published on 04/01/2026 at 11:15, 4 months 17 days ago Evotec SE to Release 2025 Financial Results Financial Results Drug Discovery Evotec SE Webcast 2025 Performance
BRIEF published on 04/01/2026 at 11:15, 4 months 17 days ago Evotec SE publiera ses résultats financiers de 2025 Résultats Financiers Evotec SE Webdiffusion Découverte De Médicaments Performances 2025
PRESS RELEASE published on 04/01/2026 at 11:10, 4 months 17 days ago Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026 Evotec SE will announce its Q4 and full-year 2025 financial results on April 8, 2026, through a webcast and conference call held in English. Learn more at www.evotec.com Financial Results Conference Call Drug Discovery Evotec SE Webcast
Published on 08/19/2026 at 04:00, 11 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 5 hours 1 minute ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 8 hours 26 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:30, 9 hours 41 minutes ago Sterling Metals Announces Approval of Arrangement by QcX Gold Shareholders
Published on 08/18/2026 at 17:40, 10 hours 31 minutes ago Largo Physical Vanadium Announces Postponement of Annual Meeting
Published on 08/18/2026 at 22:00, 6 hours 11 minutes ago Enlight Research publishes updated coverage on Eleving Group
Published on 08/18/2026 at 21:50, 6 hours 21 minutes ago Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Published on 08/18/2026 at 19:00, 9 hours 11 minutes ago HIAG strengthens sustainable financing with third green bond worth CHF 100 million
Published on 08/18/2026 at 18:45, 9 hours 26 minutes ago Information about Mr. Svetlin Todorov‘s shareholdings in Shelly Group SE
Published on 08/18/2026 at 18:10, 10 hours 1 minute ago Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home, Multimodal Cognitive Assessment in People Living with ALS and FTD
Published on 08/18/2026 at 18:00, 10 hours 11 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 10 hours 26 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 16 hours 56 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 16 hours 56 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 8 hours ago Aéroports de Paris S.A - July 2026 traffic figures
